Electrochemical Biosensors for Circulating Tumor DNA Detection

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Cancer Research

Background:

• Early cancer detection and treatment are critical for patient outcomes.
• Circulating tumor DNA (ctDNA) detection in liquid biopsies shows promise for early cancer screening.
• Traditional gene-detection technologies face challenges in cost, real-time monitoring, and portability for ctDNA analysis.

Purpose of the Study:

• To review the latest developments in electrochemical biosensors for ctDNA detection.
• To analyze biosensor designs, receptor probes, electrode modifications, and detection strategies for ctDNA.
• To explore the integration of biosensors with emerging technologies like IoT and point-of-care testing for cancer diagnostics.

Main Methods:

• Review of current literature on electrochemical biosensors for ctDNA detection.
• Analysis of sensor components including receptor probes and electrode designs.
• Evaluation of detection strategies, sample preparation, and performance metrics (figures of merit).

Main Results:

• Electrochemical biosensors provide a sensitive, specific, low-cost, and portable alternative for ctDNA detection.
• Recent advancements focus on optimizing receptor probes, electrode surfaces, and detection methodologies.
• Biosensor development is aligning with trends in portable, real-time, non-destructive diagnostics for the Internet of Things (IoT) and big health.

Conclusions:

• Electrochemical biosensors are a highly promising technology for minimally invasive, rapid, and real-time ctDNA detection.
• Further development is needed to fully realize the potential of these biosensors for widespread clinical application and point-of-care testing.
• The integration of biosensors with IoT and big data analytics will drive the future of personalized cancer diagnostics and management.